Location History:
- München, DE (2001)
- Berg, DE (2000 - 2021)
Company Filing History:
5 out of 480 
3 out of 7 
3 out of 4 Years Active: 2000-2021
Title: Erwin Soutschek: Innovator in Immunological Testing
Introduction: Erwin Soutschek, based in Berg, Germany, is a distinguished inventor with a remarkable portfolio of 12 patents. His work primarily focuses on immunological testing methods, contributing significantly to advancements in medical diagnostics and infectious disease management.
Latest Patents: Among his notable patents are the "Method for the normalization of immunological tests and kits for performing such tests" and the "Method for the immunological diagnosis of a sample with a potential infection with an arbovirus, and test kits suitable for this purpose." The first patent describes a process for normalizing immunological tests using a sandwich ELISA method, incorporating antibodies that target specific keratins, which are proteins crucial for cellular structure. The second patent provides a protocol for diagnosing potential arbovirus infections in patients, highlighting the importance of timely and accurate diagnostics in healthcare.
Career Highlights: Erwin Soutschek has played a pivotal role in the field of biomedical innovation. He has worked with prominent companies such as Roche Diagnostics GmbH, where his efforts have contributed to the development of state-of-the-art diagnostic tools and methodologies. Another significant position was with Mikrogen GmbH, where his research further advanced the understanding and application of immunological tests.
Collaborations: Throughout his career, Soutschek has collaborated closely with esteemed professionals such as Manfred Motz and Christoph Seidel. These partnerships have fostered an environment of innovation and knowledge exchange, leading to breakthroughs in immunological research and product development.
Conclusion: Erwin Soutschek stands out as an influential inventor in the realm of immunological testing. His contributions have not only revealed new methodologies for disease diagnosis but also paved the way for further innovations in medical technology. As he continues to build on his impressive portfolio, the impact of his work will undoubtedly resonate within the medical community for years to come.